If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarclays Nts45 Regulatory News (33JE)

Share Price Information for Barclays Nts45 (33JE)

Share Price is delayed by 15 minutes
Get Live Data
284.95034    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
33JE Live PriceLast checked at - London Stock Exchange

Intraday Barclays Nts45 Share Chart

Decision Notice issued by RDC regarding former CEO

12 Oct 2023 10:37

RNS Number : 9207P
Barclays PLC
12 October 2023
 

12 October 2023

Barclays PLC

and

Barclays Bank PLC

(together "Barclays")

Findings of the Regulatory Decisions Committee

The Financial Conduct Authority (the "FCA") has today published a Decision Notice issued by the Regulatory Decisions Committee ("RDC") relating to Barclays' former CEO, Jes Staley.

The Decision Notice finds that Mr Staley acted recklessly in approving a letter dated 8 October 2019 from Barclays to the FCA regarding his relationship with Jeffrey Epstein (which the RDC concluded was misleading) and, by doing so, that he breached Individual Conduct Rule 1 (acting with integrity), Individual Conduct Rule 3 (being open and cooperative with regulators) and Senior Management Conduct Rule 4 (disclosing appropriately information of which the FCA or PRA would reasonably expect notice).

Mr Staley has decided to refer the Decision Notice to the Upper Tribunal for reconsideration.

Remuneration decisions in respect of Jes Staley

As previously disclosed, the Remuneration Committee of the Board of Barclays PLC (the "Remuneration Committee") exercised its discretion to suspend all of Mr Staley's deferred bonus and LTIP awards pending further developments in respect of the regulatory and legal proceedings related to the FCA and PRA investigation regarding Mr Staley.

Following consideration of the detailed findings in the Decision Notice and the information referred to in it, the Remuneration Committee has concluded that Mr Staley should be ineligible for or forfeit a number of awards, as follows:

· his bonus award in respect of the 2021 performance year.

· his unvested LTIP awards that were still subject to performance conditions, with a face value of £14.3m, and other unvested LTIP awards for which the performance conditions had already been assessed, with a face value of £1.4m.

· his other unvested deferred bonus awards from earlier years. These awards had a face value of £2.1m, which was reduced to zero through the application of 'malus'.

The total value of the lapsed LTIP awards and forfeited deferred compensation awards was £17.8m.

 

Notes:

1. Barclays was not the subject of the FCA's investigation or the proceedings before the RDC and there are no findings made against it or any of its directors or employees in the Decision Notice. Barclays cooperated fully with the regulatory investigation.

2. All values are based on the mid-market closing share price on 10 October 2023.

 

 

- ENDS -

For further information, please contact:

Investor Relations Media Relations

Marina Shchukina Jon Tracey+44 (0) 20 7116 2526 +44 (0) 20 7116 4755

 

About Barclays

Barclays is a British universal bank. We are diversified by business, by different types of customer and client, and geography. Our businesses include consumer banking and payments operations around the world, as well as a top-tier, full service, global corporate and investment bank, all of which are supported by our service company which provides technology, operations and functional services across the Group. For further information about Barclays, please visit our website home.barclays.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCNKBBNOBDKKKD
Date   Source Headline
3rd Jul 20267:00 amRNSPricing of accelerated placing in Harbour Energy
2nd Jul 20264:49 pmRNSLaunch of accelerated placing of shares in Harbour
17th Jun 20265:50 pmRNSAdmission to Trading of Transferable Securities
5th Jun 20266:15 pmRNSDirector Declaration
28th May 20266:15 pmRNSPublication of a Supplementary Prospectus
28th Apr 20267:00 amRNSPillar 3 Report Q1 2026
11th Mar 20267:00 amRNSPricing of accelerated placing in Harbour Energy
10th Mar 20265:00 pmRNSLaunch of accelerated placing of shares in Harbour
10th Mar 20265:00 pmRNSLaunch of accelerated placing of shares in Harbour
11th Feb 20264:10 pmRNSAnnual Financial Report on Form 20-F 2025
10th Feb 20267:00 amRNSAnnual Financial Report
6th Feb 20269:00 amRNSDirectorate change
3rd Feb 20264:58 pmRNSFinal Terms
23rd Dec 20253:03 pmRNSPublication of a Supplementary Prospectus
23rd Dec 20253:03 pmRNSPublication of a Supplementary Prospectus
28th Nov 20255:14 pmRNSShawbrook Group plc Post-Stabilisation Notice
24th Nov 20255:27 pmRNSShawbrook Group plc Mid-Stabilisation Notice
13th Nov 20257:00 amRNSShawbrook Group plc Mid-Stabilisation Notice
6th Nov 20254:32 pmRNSCancellation of Securities - Replacement
5th Nov 20252:03 pmRNSCancellation of XS3100475469
30th Oct 20257:00 amRNSShawbrook Group plc Pre-Stabilisation Notice
22nd Oct 20257:00 amRNSPublication of Q3 2025 Pillar 3 Report
12th Sep 20252:40 pmRNSPublication of Final Terms
27th Aug 202512:29 pmRNSPublication of Final Terms
21st Aug 202511:20 amRNSPublication of Final Terms
1st Aug 20255:13 pmRNSPublication of Final Terms
1st Aug 20251:19 pmRNSPublication of Final Terms
1st Aug 20251:17 pmRNSPublication of Final Terms
31st Jul 20254:00 pmRNSPublication of Base Prospectus Supplement
29th Jul 20257:00 amRNSHalf-year Report
28th Jul 20254:19 pmRNSPublication of Final Terms
28th Jul 202510:41 amRNSPublication of Final Terms
28th Jul 202510:33 amRNSPublication of Final Terms
25th Jul 20253:10 pmRNSPublication of Final Terms
2nd Jul 20255:20 pmRNSPublication of Base Prospectus
1st Jul 20257:00 amRNSPricing of accelerated placing of shares in InPost
30th Jun 20254:56 pmRNSLaunch of accelerated placing of shares in InPost
24th Jun 20253:42 pmRNSPublication of Final Terms
10th Jun 202512:37 pmRNSPublication of Final Terms
10th Jun 202512:36 pmRNSPublication of Final Terms
30th May 20253:48 pmRNSPublication of Final Terms
30th May 20253:39 pmRNSPublication of Final Terms
29th May 20255:19 pmRNSPublication of Final Terms
29th May 20252:33 pmRNSPublication of Final Terms
29th May 20252:29 pmRNSPublication of Final Terms
27th May 20256:14 pmRNSPublication of Final Terms
27th May 20254:40 pmRNSPublication of Final Terms
23rd May 20253:28 pmRNSPublication of Final Terms
20th May 20254:23 pmRNSPublication of Final Terms
20th May 20254:04 pmRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.